HOME >> BIOLOGY >> NEWS
Method devised for diagnosis of ocular diseases

GAIKER-IK4 Technological Centre's Area of Biotechnology, together with the Opthtalmological Surgery Clinical Institute of Bilbao (ICQO) are co-operating in a research project the aim of which is to develop a diagnostic system, based on immunochromatographic techniques, for the specific recognition of proteic markers for ocular pathologies in eye teardrop samples.

This system, carried out with a swab (similar to pregnancy testing), will initially detect specific markers for ocular pathologies such as conjunctivochalasis and keratoconus and will enable, with a sample of teardrop liquid, the diagnosis of the patient with these disorders.

The ease of use of the system and both its speed and simplicity (a positive testing sign in the form of a coloured band) enables the system to be employed on a daily basis in the clinic. The markers on which the design of this diagnostic system is based are being analysed throughout the research project and validated by means of their recognition by specific antibodies in samples from the tears of patients affected by these pathologies.

In the future, towards the end of 2008, those responsible for the project hope to develop a multiple system, capable of detecting the presence of other ocular pathologies, besides the two already established in the initial phase, and with the aim of launching the diagnostic tests on the market.

Pathologies studied

Keratoconus or conic cornea condition is a disorder of the human eye which rarely causes blindness but can considerably interfere with vision. This pathology distorts the usual rounded shape of the cornea and forms acone-shaped prominence. It occurs in one in every two thousand persons and generally it coincides with puberty. Keratoconus does not follow any known geographical cultural or social pattern.

Conjunctivochalasis is the relaxation of the bulbar conjunctive capable of creating conjunctive folds over the lower palp
'"/>

Contact: Irati Kortabitarte
iratik@elhuyar.com
34-943-363-144
Elhuyar Fundazioa
17-Jan-2007


Page: 1 2

Related biology news :

1. Methodist, University of Houston, Cornell combine biomedical imaging expertise
2. Plants, plasmids and possibilities -- Methods permit functional gene studies in plants
3. Methodist Neurological Institute, University of Houston combine brain power
4. Method slashes quantum dot costs by 80 percent
5. Method holds promise in identifying markers of non-metastatic vs. metastatic breast cancer
6. Method shows how precisely gene expression signals are copied in DNA replication
7. Methodist, UH system joining forces for biomedical research, clinical care
8. MIDI, Inc receives Official Methods(SM) status for the confirmatory ID of the anthrax pathogen
9. Gold nanoparticles may pan out as tool for cancer diagnosis
10. Purdue-IU researchers explore new method for early disease diagnosis
11. New genetic test developed at Emory advances detection and diagnosis of muscular dystrophy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry Network for ... Design Lab . Located in Pasadena, Calif., the Design Lab’s mission is to ... are designed, built and brought to market. , The Design Lab is Supplyframe’s ...
(Date:6/23/2016)... NEWPORT BEACH, Calif. , June 23, 2016 /PRNewswire/ ... offering new biological discoveries to the medical community, has ... and co-founder Matthew Nunez . "We ... provide us with the capital we need to meet ... funding will essentially provide us the runway to complete ...
Breaking Biology Technology:
Cached News: